Interpersonal Psychotherapy for adolescents with depression
Official title: Interpersonal Psychotherapy for Adolescents and Young Adults
Run by Linnaeus University · NCT05575960 · Data updated 2026-11-12
This study is testing if Interpersonal Psychotherapy can help teenagers with major depression feel better by improving their emotions and social connections.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 15 Years to 18 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Linnaeus University Academic / other |
| Locations | 1 site (Norrköping) |
| Status | Recruiting |
| Started | October 3, 2022 |
| Main results expected | December 31, 2026 |
| Study ends | June 15, 2027 |
| Registry record updated | May 20, 2024 |
| Trial ID | NCT05575960 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adolescents aged 15 to 17.5 years diagnosed with major depressive disorder.
✕Probably not a fit
Patients with ongoing psychosis, severe depression requiring hospitalization, or those with substance abuse issues may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to evaluate the effectiveness of Interpersonal Psychotherapy (IPT) specifically for adolescents suffering from major depression. Over four years, the study will recruit 60 patients and utilize a quasi-experimental multiple-baseline design to assess treatment outcomes. Key aspects being analyzed include change mechanisms such as mentalizing, emotion regulation, and social support, along with predictors of treatment effectiveness. The implementation of IPT will also be examined through qualitative interviews with participants and their families.
Why it matters
Potential benefit: If successful, this study could provide an effective therapeutic approach for adolescents dealing with major depression.
How similar studies have gone: Previous studies have shown positive outcomes for IPT in treating depression, suggesting that this approach may be effective for adolescents as well.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Major depressive disorder according to the DSM-V * Age 15 to 17,5 years. * Good-enough knowledge in Swedish to be able to read instructions in questionnaires and who do not require an interpreter. Exclusion Criteria: * Ongoing psychosis * Drug or alcohol addiction * Bipolar disorder * Suspected mental retardation * Acute suicidality or severe depression requiring hospitalization * Patients who have started antidepressant medication within the last six weeks will need to wait until medication effects have stabilized.
Where it's running
-
Norrköping Child and Adolescent Psychiatric Services (BUP Norrköping)
Norrköping, Sweden Recruiting
Study contacts
- Principal investigator: Fredrik Falkenström, PhD — Linnaeus University
- Study coordinator: Fredrik Falkenström, PhD
- Email: fredrik.falkenstrom@lnu.se
- Phone: +46701089877
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Can tACS modulate motivation and reward signals in cannabis use disorder and depression
We’re testing whether a gentle brain stimulation method (tACS) can boost motivation and reward responses in adults with cannabis use and/or depression to see if it helps with anhedonia.
-
Neural links for real-world emotions in mood and anxiety
Researchers are testing how real-life emotional moments relate to brain activity and stress responses in young adults with mood and anxiety symptoms, using smartphones, self-reports, tasks, and MRI.
-
EEG-Guided TMS for Adults With Depression
This study tests whether delivering intermittent theta burst stimulation (iTBS) timed to brain waves using EEG can improve treatment for adults with major depressive disorder who have not responded to usual antidepressants.
-
iTBS to help anhedonia in depression (dual left DLPFC + OFC or left DLPFC alone)
A brain stimulation study tests whether intermittent theta burst stimulation can help people with major depression who have anhedonia, using both dual-target (left DLPFC and OFC) and single-target (left DLPFC) approaches.
-
One Day of Ultra-Accelerated TMS With a Dose of NRX-101 for Major Depression
This study tests whether a single day of rapid TMS plus NRX-101 can help people with moderate to severe depression see improvement over six weeks.
-
EEG microstates and inflammatory markers in treatment-resistant depression patients undergoing ECT
This study tests how electroconvulsive therapy affects brain activity patterns seen in EEG and inflammatory biomarkers in adults with treatment-resistant major depression.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.